Nominations Open for the Merkin Prize in Biomedical Technology
CAMBRIDGE, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) — Nominations are now open for the first award of the Richard N. Merkin Prize in Biomedical Technology, which…
Day: November 29, 2022
Nominations Open for the Merkin Prize in Biomedical Technology
CAMBRIDGE, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) — Nominations are now open for the first award of the Richard N. Merkin Prize in Biomedical Technology, which…
Nominations Open for the Merkin Prize in Biomedical Technology
CAMBRIDGE, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) — Nominations are now open for the first award of the Richard N. Merkin Prize in Biomedical Technology, which…
Alchip Technologies Q3 Revenue Sets Fiscal Year ’22 Record
Operating Income and Net Income Up Year-on-Year Taipei, Taiwan, Nov. 29, 2022 (GLOBE NEWSWIRE) — Alchip Technologies set a fiscal year 2022 record with Q3…
Alchip Technologies Q3 Revenue Sets Fiscal Year ’22 Record
Operating Income and Net Income Up Year-on-Year Taipei, Taiwan, Nov. 29, 2022 (GLOBE NEWSWIRE) — Alchip Technologies set a fiscal year 2022 record with Q3…
Alchip Technologies Q3 Revenue Sets Fiscal Year ’22 Record
Operating Income and Net Income Up Year-on-Year Taipei, Taiwan, Nov. 29, 2022 (GLOBE NEWSWIRE) — Alchip Technologies set a fiscal year 2022 record with Q3…
Jeito Capital demonstrates European biopharma leadership with first exit with AstraZeneca acquisition of Neogene Therapeutics
Jeito Capital demonstrates European biopharma leadership with first exit with AstraZeneca acquisition of Neogene Therapeutics Deal validates Jeito’s unique investment model of selecting high–quality assets…